Clearstead Trust’s AdaptHealth AHCO Stock Holding History

Clearstead Trust’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-51	Closed	-$457	–	1018
2025 Q3	$457	Hold	51	–	–	﹤0.01%	1389
2025 Q2	$481	Buy	+51	New	+$450	﹤0.01%	1338

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Clearstead Trust's AHCO Position: Q4 2025 in Review

Clearstead Trust sold out of AdaptHealth (AHCO) in Q4 2025, closing a stake of 51 shares — an estimated $457 sold.

Clearstead Trust first reported a position in AHCO in Q2 2025 and held it in 2 quarters. The position peaked at $481 in Q2 2025. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

Clearstead Trust reported no remaining AdaptHealth position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 51 AdaptHealth shares in Q4 2025, an estimated $457.
Clearstead Trust first reported a position in AdaptHealth in Q2 2025 and held it in 2 quarters.
Clearstead Trust's AdaptHealth position peaked at $481 in Q2 2025.
231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.